Skip to content

sertraline effect on stroke

A study of sertraline effect on quality of life in stroke inpatients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012101011062N1
Enrollment
80
Registered
2012-11-28
Start date
2012-09-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke. Stroke, not specified as haemorrhage or infarction

Interventions

Intervention 1: Intervention:3 weeks after stroke each patient in this group reseived Sertraline 50 mg per day for 12 months. Intervention 2: control: 3 weeks after stroke each patient in this group
Treatment - Drugs
Placebo
Intervention:3 weeks after stroke each patient in this group reseived Sertraline 50 mg per day for 12 months.
control: 3 weeks after stroke each patient in this group reseived a placebo tablet every day.

Sponsors

Tabriz University of medical sciences, Vice chancellor of research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: inpatients which are experiencing stroke for the first time will be enrolled.Exclusion criteria: past history of stroke ;renal failure; hepatic failure; cardiac failure; substance related disorders

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Quality of life. Timepoint: 3 months, 6 months, 9 months. Method of measurement: Nottingham Health Profile.

Secondary

MeasureTime frame
Depression. Timepoint: 3 months, 6 months, 9 months. Method of measurement: Beck depression inventory.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Pirzeh

Department of Psychiatry

pirzehr@tbzmed.ac.ir rezapirzeh@gmail.com+98 41 1380 3353

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026